Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.960 +0.560 (+10.37%)
Streaming Delayed Price Updated: 3:20 PM EDT, Aug 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,292
Open 5.300
Bid (Size) 5.860 (500)
Ask (Size) 6.000 (400)
Prev. Close 5.400
Today's Range 5.300 - 6.150
52wk Range 1.900 - 10.59
Shares Outstanding 620,290
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Researchers Identify a Protein That Could Be Targeted in Glioblastoma Therapy
Via Investor Brand Network
NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 Results as Strategic Pivot Advances
Via Investor Brand Network

Performance

YTD
+12.5%
+12.5%
1 Month
+8.4%
+8.4%
3 Month
+26.5%
+26.5%
6 Month
+82.8%
+82.8%
1 Year
-3.7%
-3.7%

More News

Read More
News headline image
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
From CNS Pharmaceuticals, Inc.
Via ACCESS Newswire
Focused Ultrasound Shows Promise in Treating Brain Tumors
Via Investor Brand Network
Spanish Patient Highlights Risks of Poorly Cooked Pork
Via Investor Brand Network
Collagen Tiles Could Prevent Brain Cancer Recurrence
Via Investor Brand Network
Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment
Via Investor Brand Network
Experimental Immunotherapy Offers Hope Against Deadly Pediatric Brain Cancer
Via Investor Brand Network
Study Finds No Evidence That Mobile Phones Can Cause Brain Cancer
Via Investor Brand Network
Widely Prescribed Thyroid Hormone Could Prevent Pediatric Brain Tumor Recurrence
Via Investor Brand Network
New Vaccine Gives Brain Cancer Patients Hope of Longer Survival
Via Investor Brand Network
Scientists Find Targeting Enzyme That Could Block Brain Metastases
Via Investor Brand Network
WashU Vaccine Could Revolutionize Personalized Glioblastoma Treatment
Via Investor Brand Network
Study Links TBI to Higher Mortality Risk Due to Brain Cancer
Via Investor Brand Network
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation
Via Investor Brand Network
News headline image
CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment
Via ACCESS Newswire
Pediatric Brain Tumors Spread Faster as Immune Cells Build Enabling Scaffolding
Via Investor Brand Network
Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment
Via Investor Brand Network
Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment
Via Investor Brand Network
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
Study Finds That Errors in Brain Cell Division Could Trigger Cancer
Via Investor Brand Network
Study Suggests Testosterone Slows Glioblastoma Progression in Men
Via Investor Brand Network
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports First-Quarter 2026 Results, Advances Strategic Transformation
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
Via ACCESS Newswire
Blocking Fructose Metabolism Boosts Immune Response to Childhood Cancer
Via Investor Brand Network

Frequently Asked Questions

Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
The current price of CNS Pharmaceuticals, Inc. - Common Stock is 5.960
When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 08/18/26 03:20 PM ET
What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 3.70M
How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
CNS Pharmaceuticals, Inc. - Common Stock has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.